116 related articles for article (PubMed ID: 2570732)
1. Use of microbleeding and an ultrathin endoscope to assess gastric mucosal protection by famotidine.
Daneshmend TK; Prichard PJ; Bhaskar NK; Millns PJ; Hawkey CJ
Gastroenterology; 1989 Oct; 97(4):944-9. PubMed ID: 2570732
[TBL] [Abstract][Full Text] [Related]
2. Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers.
Nishino M; Sugimoto M; Kodaira C; Yamade M; Uotani T; Shirai N; Ikuma M; Tanaka T; Sugimura H; Hishida A; Furuta T
J Clin Pharmacol; 2011 Jul; 51(7):1079-86. PubMed ID: 20663999
[TBL] [Abstract][Full Text] [Related]
3. Ranitidine bismuth citrate and aspirin-induced gastric mucosal injury.
Hudson N; Murray FE; Cole AT; Turnbull GM; Lettis S; Hawkey CJ
Aliment Pharmacol Ther; 1993 Oct; 7(5):515-21. PubMed ID: 7904188
[TBL] [Abstract][Full Text] [Related]
4. Ranitidine: differential effects on gastric bleeding and mucosal damage induced by aspirin.
Cole AT; Brundell S; Hudson N; Hawthorne AB; Mahida YR; Hawkey CJ
Aliment Pharmacol Ther; 1992 Dec; 6(6):707-15. PubMed ID: 1486156
[TBL] [Abstract][Full Text] [Related]
5. A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.
Yamaguchi Y; Katsumi N; Tauchi M; Toki M; Nakamura K; Aoki K; Morita Y; Miura M; Morozumi K; Ishida H; Takahashi S
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():111-5. PubMed ID: 15943857
[TBL] [Abstract][Full Text] [Related]
6. Failure of ethamsylate to reduce aspirin-induced gastric mucosal bleeding in humans.
Daneshmend TK; Stein AG; Bhaskar NK; Hawkey CJ
Br J Clin Pharmacol; 1989 Jul; 28(1):109-12. PubMed ID: 2789070
[TBL] [Abstract][Full Text] [Related]
7. Enhanced gastric mucosal bleeding with doses of aspirin used for prophylaxis and its reduction by ranitidine.
Kitchingman GK; Prichard PJ; Daneshmend TK; Walt RP; Hawkey CJ
Br J Clin Pharmacol; 1989 Nov; 28(5):581-5. PubMed ID: 2590612
[TBL] [Abstract][Full Text] [Related]
8. Gastric protection by nocloprost against aspirin damage in humans. Possible role of epidermal growth factor.
Konturek SJ; Konturek JW; Kwiecien N; Obtułowicz W; Oleksy J; Hebzda Z; Amon I
Scand J Gastroenterol; 1991 Mar; 26(3):231-6. PubMed ID: 1853145
[TBL] [Abstract][Full Text] [Related]
9. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
Taha AS; McCloskey C; Prasad R; Bezlyak V
Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798
[TBL] [Abstract][Full Text] [Related]
10. Prevention of aspirin-induced gastric mucosal injury by histamine H2 receptor antagonists: a crossover endoscopic and intragastric pH study in the dog.
Cavanagh RL; Buyniski JP; Schwartz SE
J Pharmacol Exp Ther; 1987 Dec; 243(3):1179-84. PubMed ID: 2891837
[TBL] [Abstract][Full Text] [Related]
11. Omeprazole vs famotidine for the prevention of gastroduodenal injury in high-risk users of low-dose aspirin: A randomized controlled trial.
Tseng ZF; Hsu PI; Peng NJ; Kao SS; Tsay FW; Cheng JS; Chen WC; Tsai KF; Tang SY; Chuah SK; Shie CB
J Chin Med Assoc; 2021 Jan; 84(1):19-24. PubMed ID: 33230059
[TBL] [Abstract][Full Text] [Related]
12. Separation of the impairment of haemostasis by aspirin from mucosal injury in the human stomach.
Hawkey CJ; Hawthorne AB; Hudson N; Cole AT; Mahida YR; Daneshmend TK
Clin Sci (Lond); 1991 Oct; 81(4):565-73. PubMed ID: 1657506
[TBL] [Abstract][Full Text] [Related]
13. Reduction of endoscopically assessed acute aspirin-induced gastric mucosal injury with cimetidine.
Kimmey MB; Silverstein FE; Saunders DR; Chapman RC
Dig Dis Sci; 1987 Aug; 32(8):851-6. PubMed ID: 3301232
[TBL] [Abstract][Full Text] [Related]
14. Plasma famotidine concentration versus intragastric pH in patients with upper gastrointestinal bleeding and in healthy subjects.
Echizen H; Shoda R; Umeda N; Ishizaki T
Clin Pharmacol Ther; 1988 Dec; 44(6):690-8. PubMed ID: 2904311
[TBL] [Abstract][Full Text] [Related]
15. Prevention of acute aspirin-induced gastric mucosal injury by 15-R-15 methyl prostaglandin E2: an endoscopic study.
Gilbert DA; Surawicz CM; Silverstein FE; Weinberg CR; Saunders DR; Feld AD; Sanford RL; Bergman D; Washington P
Gastroenterology; 1984 Feb; 86(2):339-45. PubMed ID: 6360786
[TBL] [Abstract][Full Text] [Related]
16. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis of aspirin-induced gastric mucosal bleeding with ranitidine.
Hawkey CJ; Somerville KW; Marshall S
Aliment Pharmacol Ther; 1988 Jun; 2(3):245-52. PubMed ID: 2979248
[TBL] [Abstract][Full Text] [Related]
18. [I.v. famotidine versus i.v. ranitidine: intragastric pH behavior in surgical intensive care patients].
Friedl W; Krier C; Dammann HG; Müller P; Simon B
Z Gastroenterol; 1985 Nov; 23(11):603-7. PubMed ID: 2868579
[TBL] [Abstract][Full Text] [Related]
19. Effects of ebrotidine on aspirin-induced gastric mucosal damage and blood flow in humans.
Konturek SJ; Kwiecien N; Sito E; Obtulowicz W; Kaminski K; Oleksy J
Scand J Gastroenterol; 1993 Dec; 28(12):1047-50. PubMed ID: 7905660
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin protection of the human gastric mucosa against alcohol-induced injury. Endoscopic, histologic, and functional assessment.
Tarnawski A; Hollander D; Stachura J; Klimczyk B; Mach T; Bogdal J
Scand J Gastroenterol Suppl; 1986; 125():165-9. PubMed ID: 3493523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
